David E. Potter

Title
InstitutionMedical University of South Carolina
DepartmentOphthalmology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Potter DE, Choudhury M, Potter DE, Choudhury M. Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today. 2014 Dec; 19(12):1848-54. PMID: 25224017.
      Citations:    
    2. Husain S, Abdul Y, Potter DE, Husain S, Abdul Y, Potter DE. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012; 18(37):6101-8. PMID: 22747547.
      Citations:    
    3. Paes KT, Wang E, Henze K, Vogel P, Read R, Suwanichkul A, Kirkpatrick LL, Potter D, Newhouse MM, Rice DS, Paes KT, Wang E, Henze K, Vogel P, Read R, Suwanichkul A, Kirkpatrick LL, Potter D, Newhouse MM, Rice DS. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest Ophthalmol Vis Sci. 2011 Aug 16; 52(9):6452-61. PMID: 21743011.
      Citations:    
    4. Husain S, Potter DE, Crosson CE, Husain S, Potter DE, Crosson CE. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3853-9. PMID: 19324855.
      Citations:    
    5. Husain S, Potter DE, Husain S, Potter DE. The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther. 2008 Apr; 24(2):117-40. PMID: 18355128.
      Citations:    
    6. Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA, Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology. 2008 Oct; 33(11):2676-87. PMID: 18185499; PMCID: PMC2564810.
      Citations:    
    7. Dortch-Carnes J, Potter DE, Dortch-Carnes J, Potter DE. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212. PMID: 16007240; PMCID: PMC6741727.
      Citations:    
    8. Potter DE, Russell KR, Manhiani M, Potter DE, Russell KR, Manhiani M. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53. PMID: 14742737.
      Citations: 8     Fields:    Translation:Animals
    9. Dortch-Carnes J, Potter DE, Dortch-Carnes J, Potter DE. Delta-opioid agonist-stimulated inositol phosphate formation in isolated, rabbit iris-ciliary bodies: role of G(i/o) proteins and Gbetagamma-subunits. Exp Eye Res. 2003 Dec; 77(6):647-52. PMID: 14609552.
      Citations: 6     Fields:    Translation:Animals
    10. von Deutsch DA, Abukhalaf IK, Wineski LE, Silvestrov NA, Bayorh MA, Potter DE, von Deutsch DA, Abukhalaf IK, Wineski LE, Silvestrov NA, Bayorh MA, Potter DE. Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment. Can J Physiol Pharmacol. 2003 Jan; 81(1):28-39. PMID: 12665255.
      Citations: 1     Fields:    Translation:Animals
    11. Chu TC, He Q, Potter DE, Chu TC, He Q, Potter DE. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. J Ocul Pharmacol Ther. 2002 Dec; 18(6):507-14. PMID: 12537677.
      Citations: 4     Fields:    Translation:AnimalsPHPublic Health
    12. Ogidigben MJ, Potter DE, Ogidigben MJ, Potter DE. Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function. Curr Eye Res. 2002 Nov; 25(5):267-70. PMID: 12658545.
      Citations:    Fields:    Translation:Animals
    13. Chu TC, Potter DE, Chu TC, Potter DE. Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther. 2002 Aug; 18(4):293-305. PMID: 12222760.
      Citations: 6     Fields:    Translation:Animals
    14. Abukhalaf IK, von Deutsch DA, Wineski LE, Silvestrov NA, Abera SA, Sahlu SW, Potter DE, Abukhalaf IK, von Deutsch DA, Wineski LE, Silvestrov NA, Abera SA, Sahlu SW, Potter DE. Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscle. Pharmacology. 2002 Jul; 65(3):145-54. PMID: 12037378.
      Citations: 4     Fields:    Translation:AnimalsCells
    15. Ogidigben MJ, Chu TC, Potter DE, Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61. PMID: 12037379.
      Citations: 1     Fields:    Translation:Animals
    16. von Deutsch DA, Abukhalaf IK, Wineski LE, Roper RR, Aboul-Enein HY, Paulsen DF, Potter DE, von Deutsch DA, Abukhalaf IK, Wineski LE, Roper RR, Aboul-Enein HY, Paulsen DF, Potter DE. Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats. Pharmacology. 2002 May; 65(1):38-48. PMID: 11901300.
      Citations: 4     Fields:    Translation:AnimalsCells
    17. Wineski LE, von Deutsch DA, Abukhalaf IK, Pitts SA, Potter DE, Paulsen DF, Wineski LE, von Deutsch DA, Abukhalaf IK, Pitts SA, Potter DE, Paulsen DF. Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. Cells Tissues Organs. 2002; 171(2-3):188-98. PMID: 12097841.
      Citations: 13     Fields:    Translation:HumansAnimals
    18. Russell KR, Moore TT, Potter DE, Russell KR, Moore TT, Potter DE. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7. PMID: 12030807.
      Citations: 3     Fields:    Translation:Animals
    19. Moore TT, Potter DE, Moore TT, Potter DE. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001 Aug; 73(2):167-78. PMID: 11446767.
      Citations: 4     Fields:    Translation:Animals
    20. Ogidigben MJ, Potter DE, Ogidigben MJ, Potter DE. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics. Curr Eye Res. 2001 May; 22(5):358-66. PMID: 11600937.
      Citations: 1     Fields:    Translation:Animals
    21. Ogidigben MJ, Chu TC, Potter DE, Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar; 72(3):331-9. PMID: 11180982.
      Citations: 2     Fields:    Translation:Animals
    22. von Deutsch DA, Abukhalaf IK, Wineski LE, Aboul-Enein HY, Pitts SA, Parks BA, Oster RA, Paulsen DF, Potter DE, von Deutsch DA, Abukhalaf IK, Wineski LE, Aboul-Enein HY, Pitts SA, Parks BA, Oster RA, Paulsen DF, Potter DE. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality. 2000 Aug; 12(8):637-48. PMID: 10897101.
      Citations: 3     Fields:    Translation:Animals
    23. Zhou L, Thompson WJ, Potter DE, Zhou L, Thompson WJ, Potter DE. Functional identification of phosphodiesterase activity in human trabecular meshwork cells. J Ocul Pharmacol Ther. 2000 Aug; 16(4):317-22. PMID: 10977127.
      Citations: 1     Fields:    Translation:HumansCells
    24. Chu E, Chu TC, Potter DE, Chu E, Chu TC, Potter DE. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6. PMID: 10869368.
      Citations: 4     Fields:    Translation:Animals
    25. Russell KR, Wang DR, Potter DE, Russell KR, Wang DR, Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May; 70(5):675-82. PMID: 10870526.
      Citations: 7     Fields:    Translation:Animals
    26. Abukhalaf IK, von Deutsch DA, Parks BA, Wineski L, Paulsen D, Aboul-Enein HY, Potter DE, Abukhalaf IK, von Deutsch DA, Parks BA, Wineski L, Paulsen D, Aboul-Enein HY, Potter DE. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed Chromatogr. 2000 Apr; 14(2):99-105. PMID: 10694703.
      Citations:    Fields:    Translation:Animals
    27. Chu E, Chu TC, Potter DE, Chu E, Chu TC, Potter DE. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res. 1999 Dec; 69(6):611-6. PMID: 10620390.
      Citations: 2     Fields:    Translation:Animals
    28. Chu TC, Ogidigben MJ, Potter DE, Chu TC, Ogidigben MJ, Potter DE. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action. Exp Eye Res. 1999 Aug; 69(2):227-38. PMID: 10433858.
      Citations: 3     Fields:    Translation:Animals
    29. Zhou L, Thompson WJ, Potter DE, Zhou L, Thompson WJ, Potter DE. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1745-52. PMID: 10393044.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    30. Ogidigben MJ, Chu TC, Potter DE, Ogidigben MJ, Chu TC, Potter DE. Peripheral and central effects of naphazoline on ocular hydrodynamics. Involvement of imidazoline receptors, ANP, and Gi proteins. Ann N Y Acad Sci. 1999 Jun 21; 881:388-91. PMID: 10415943.
      Citations:    Fields:    Translation:Animals
    31. Chu TC, Han P, Han G, Potter DE, Chu TC, Han P, Han G, Potter DE. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits. J Ocul Pharmacol Ther. 1999 Feb; 15(1):9-17. PMID: 10048343.
      Citations:    Fields:    Translation:Animals
    32. Potter DE, Ogidigben MJ, Chu TC, Potter DE, Ogidigben MJ, Chu TC. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology. 1998 Nov; 57(5):249-60. PMID: 9742290.
      Citations: 3     Fields:    Translation:Animals
    33. Chu TC, Socci RR, Ogidigben MJ, Potter DE, Chu TC, Socci RR, Ogidigben MJ, Potter DE. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96. PMID: 9436152.
      Citations:    Fields:    Translation:Animals
    34. Chu TC, Socci RR, Potter DE, Chu TC, Socci RR, Potter DE. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6. PMID: 9396081.
      Citations:    Fields:    Translation:Animals
    35. Chu TC, Ogidigben MJ, Potter DE, Chu TC, Ogidigben MJ, Potter DE. Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics. Pharmacology. 1996 Oct; 53(4):259-70. PMID: 8958565.
      Citations: 2     Fields:    Translation:Animals
    36. Chu TC, Wong W, Gluchowski C, Hughes BW, Potter DE, Chu TC, Wong W, Gluchowski C, Hughes BW, Potter DE. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50. PMID: 8921215.
      Citations:    Fields:    Translation:Animals
    37. Chu TC, Burch JL, de Paula Brotto MA, Creazzo TL, Han J, Han GY, Potter DE, Chu TC, Burch JL, de Paula Brotto MA, Creazzo TL, Han J, Han GY, Potter DE. Elevation of intracellular Ca2+ concentration in rabbit nonpigmented ciliary epithelial cells by allicin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Sep; 115(1):89-94. PMID: 8983172.
      Citations:    Fields:    Translation:AnimalsCells
    38. Wang D, Potter DE, Wang D, Potter DE. Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther. 1996; 12(2):131-9. PMID: 8773929.
      Citations: 2     Fields:    Translation:Animals
    39. Campbell WR, Potter DE, Campbell WR, Potter DE. Centrally mediated ocular hypotension: potential role of imidazoline receptors. Ann N Y Acad Sci. 1995 Jul 12; 763:463-85. PMID: 7677360.
      Citations:    Fields:    Translation:Animals
    40. Campbell WR, Potter DE, Campbell WR, Potter DE. The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct; 18(6):1051-61. PMID: 7824759.
      Citations:    Fields:    Translation:Animals
    41. Ogidigben M, Chu TC, Potter DE, Ogidigben M, Chu TC, Potter DE. Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin. Exp Eye Res. 1994 Jun; 58(6):729-36. PMID: 7925712.
      Citations: 5     Fields:    Translation:Animals
    42. Ogidigben M, Chu TC, Potter DE, Ogidigben M, Chu TC, Potter DE. Ocular actions of moxonidine: a possible role for imidazoline receptors. J Pharmacol Exp Ther. 1994 Jun; 269(3):897-904. PMID: 7912282.
      Citations: 1     Fields:    Translation:AnimalsCells
    43. Campbell WR, Potter DE, Campbell WR, Potter DE. Potential role of imidazoline (I1) receptors in modulating aqueous humor dynamics. J Ocul Pharmacol. 1994; 10(1):393-402. PMID: 8207342.
      Citations: 1     Fields:    Translation:Animals
    44. Ogidigben M, Chu TC, Potter DE, Ogidigben M, Chu TC, Potter DE. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7. PMID: 7902435.
      Citations: 2     Fields:    Translation:Animals
    45. Potter DE, Ogidigben MJ, Heath AR, Potter DE, Ogidigben MJ, Heath AR. Ocular actions of an octahydrobenzo[f]quinoline: Ha117. Eur J Pharmacol. 1993 May 12; 236(1):61-8. PMID: 8100528.
      Citations: 1     Fields:    Translation:Animals
    46. Chu TC, Ogidigben M, Han JC, Potter DE, Chu TC, Ogidigben M, Han JC, Potter DE. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol. 1993; 9(3):201-9. PMID: 8228529.
      Citations: 3     Fields:    Translation:AnimalsCells
    47. Ogidigben MJ, Potter DE, Ogidigben MJ, Potter DE. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits. J Ocul Pharmacol. 1993; 9(3):187-99. PMID: 7901309.
      Citations: 1     Fields:    Translation:Animals
    48. Crosson CE, Heath AR, DeVries GW, Potter DE, Crosson CE, Heath AR, DeVries GW, Potter DE. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res. 1992 Oct; 11(10):963-70. PMID: 1360396.
      Citations: 5     Fields:    Translation:Animals
    49. Potter DE, Ogidigben MJ, Potter DE, Ogidigben MJ. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane. Invest Ophthalmol Vis Sci. 1991 Sep; 32(10):2799-805. PMID: 1680113.
      Citations: 3     Fields:    Translation:Animals
    50. Potter DE, Burke JA, Ogidigben MJ, Potter DE, Burke JA, Ogidigben MJ. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits. J Auton Pharmacol. 1990 Jun; 10(3):153-61. PMID: 1974256.
      Citations:    Fields:    Translation:AnimalsCells
    51. Crosson CE, Burke JA, Chan MF, Potter DE, Crosson CE, Burke JA, Chan MF, Potter DE. Prejunctional adrenoceptor activity of N-0437: a relatively selective DA2 dopamine receptor agonist. Eur J Pharmacol. 1990 Mar 27; 178(3):351-5. PMID: 1971223.
      Citations:    Fields:    Translation:Animals
    52. Potter DE, Crosson CE, Heath AR, Ogidigben MJ, Potter DE, Crosson CE, Heath AR, Ogidigben MJ. Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential. J Ocul Pharmacol. 1990; 6(3):251-7. PMID: 1981221.
      Citations: 5     Fields:    Translation:Animals
    53. Crosson CE, Willis JA, Potter DE, Crosson CE, Willis JA, Potter DE. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990; 6(4):293-9. PMID: 2097313.
      Citations: 14     Fields:    Translation:Animals
    54. Potter DE, Crosson CE, Heath AR, Ogidigben MJ, Potter DE, Crosson CE, Heath AR, Ogidigben MJ. Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60. PMID: 2177194.
      Citations: 1     Fields:    Translation:Animals
    55. Potter DE, Shumate DJ, Bundgaard H, Lee VH, Potter DE, Shumate DJ, Bundgaard H, Lee VH. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol. Curr Eye Res. 1988 Aug; 7(8):755-9. PMID: 2903009.
      Citations:    Fields:    Translation:Animals
    56. Potter DE, Burke JA, Potter DE, Burke JA. LY141865: a relatively selective DA2 agonist with complex ocular activity. J Ocul Pharmacol. 1988; 4(1):19-28. PMID: 2902177.
      Citations: 2     Fields:    Translation:Animals
    57. Crosson CE, Burke JA, Chan MF, Potter DE, Crosson CE, Burke JA, Chan MF, Potter DE. Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action. Curr Eye Res. 1987 Nov; 6(11):1319-26. PMID: 3427980.
      Citations:    Fields:    Translation:Animals
    58. Burke JA, Potter DE, Burke JA, Potter DE. Aporphine derivatives affect ocular function in diverse ways. Curr Eye Res. 1987 Oct; 6(10):1227-36. PMID: 3677783.
      Citations:    Fields:    Translation:Animals
    59. Potter DE, Shumate DJ, Potter DE, Shumate DJ. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function. J Ocul Pharmacol. 1987; 3(4):309-21. PMID: 3503920.
      Citations: 6     Fields:    Translation:AnimalsCells
    60. Burke JA, Potter DE, Burke JA, Potter DE. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Curr Eye Res. 1986 Sep; 5(9):665-76. PMID: 2876846.
      Citations: 7     Fields:    Translation:AnimalsCells
    61. Phipps TL, Potter DE, Rowland JM, Phipps TL, Potter DE, Rowland JM. Effects of ibuterol, a beta-2 adrenergic prodrug, on intraocular pressure. J Ocul Pharmacol. 1986; 2(3):225-37. PMID: 3503109.
      Citations:    Fields:    Translation:Animals
    62. Burke JA, Potter DE, Burke JA, Potter DE. The ocular effects of xylazine in rabbits, cats, and monkeys. J Ocul Pharmacol. 1986; 2(1):9-21. PMID: 3503099.
      Citations: 11     Fields:    Translation:Animals
    63. Potter DE, Burke JA, Temple JR, Potter DE, Burke JA, Temple JR. Forskolin suppresses sympathetic neuron function and causes ocular hypotension. Curr Eye Res. 1985 Feb; 4(2):87-96. PMID: 4039243.
      Citations: 2     Fields:    Translation:AnimalsCells
    64. Chang FW, Burke JA, Potter DE, Chang FW, Burke JA, Potter DE. Mechanism of the ocular hypotensive action of ketanserin. J Ocul Pharmacol. 1985; 1(2):137-47. PMID: 3880071.
      Citations: 6     Fields:    Translation:Animals
    65. Potter DE, Burke JA, Potter DE, Burke JA. An in vivo model for dissociating alpha 2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation. Curr Eye Res. 1984 Nov; 3(11):1289-98. PMID: 6150810.
      Citations: 1     Fields:    Translation:AnimalsCells
    66. Burke JA, Chang FW, Potter DE, Burke JA, Chang FW, Potter DE. Effects of aminotetralins on intraocular pressure and pupillary function in rabbits. J Auton Pharmacol. 1984 Sep; 4(3):185-92. PMID: 6490680.
      Citations:    Fields:    Translation:Animals
    67. Potter DE, Burke JA, Chang FW, Potter DE, Burke JA, Chang FW. Alteration in ocular function induced by phenylethylamine analogs of dopamine. Curr Eye Res. 1984 Jun; 3(6):851-9. PMID: 6329603.
      Citations: 3     Fields:    Translation:Animals
    68. Potter DE, Burke JA, Chang FW, Potter DE, Burke JA, Chang FW. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr Eye Res. 1984 Feb; 3(2):307-14. PMID: 6142811.
      Citations: 10     Fields:    Translation:Animals
    69. Potter DE, Burke JA, Potter DE, Burke JA. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982-1983; 2(5):281-8. PMID: 6131794.
      Citations: 8     Fields:    Translation:HumansAnimals
    70. Potter DE, Nicholson HT, Rowland JM, Potter DE, Nicholson HT, Rowland JM. Ocular hypertensive response to beta-adrenoceptor agonists. Curr Eye Res. 1982-1983; 2(10):711-9. PMID: 6137324.
      Citations:    Fields:    Translation:Animals
    71. Potter DE, Morris JW, Rowland JM, Potter DE, Morris JW, Rowland JM. Effects of ethanol, acetaldehyde and acetate on insulin release from perifused pancreatic islets. Pharmacology. 1982; 24(5):314-20. PMID: 7048345.
      Citations: 1     Fields:    Translation:Animals
    72. Orr RK, Hoehn JL, Col NF, Potter DE. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol Rev. 1981 Sep; 33(3):133-53. PMID: 7323134.
      Citations: 6     Fields:    Translation:HumansAnimals
    73. Rowland JM, Potter DE, Reiter RJ, Rowland JM, Potter DE, Reiter RJ. Circadian rhythm in intraocular pressure: a rabbit model. Curr Eye Res. 1981; 1(3):169-73. PMID: 7297102.
      Citations: 27     Fields:    Translation:Animals
    74. Rowland JM, Potter DE, Rowland JM, Potter DE. Steric structure activity relationships of various adrenergic agonists: ocular and systemic effects. Curr Eye Res. 1981; 1(1):25-35. PMID: 6117417.
      Citations: 1     Fields:    Translation:Animals
    75. Potter DE, Rowland JM, Potter DE, Rowland JM. Adrenergic drugs and intraocular pressure. Gen Pharmacol. 1981; 12(1):1-13. PMID: 7250663.
      Citations:    Fields:    Translation:HumansAnimals
    76. Rowland JM, Potter DE, Lombardini JB, Rowland JM, Potter DE, Lombardini JB. Taurine concentrations in the aqueous humor and plasma of anesthetized rabbits. Experientia. 1980 Aug 15; 36(8):980-1. PMID: 7439337.
      Citations: 1     Fields:    Translation:Animals
    77. Orr RK, Hoehn JL, Col NF, Rowland JM, Potter DE. The effects of topical prazosin on normal and elevated intraocular pressure and blood pressure in rabbits. Eur J Pharmacol. 1980 Jun 27; 64(4):361-3. PMID: 7389829.
      Citations: 1     Fields:    Translation:Animals
    78. Rowland JM, Potter DE, Rowland JM, Potter DE. Adrenergic drugs and intraocular pressure: suppression of ocular hypertension induced by water loading. Exp Eye Res. 1980 Jan; 30(1):93-104. PMID: 6102526.
      Citations: 5     Fields:    Translation:Animals
    79. Potter DE, Chin CA, Rowland JM, Potter DE, Chin CA, Rowland JM. Acute pretreatment with pyrazole and ethanol: effects on glucose-induced changes in insulin and glucagon. Pharmacology. 1980; 20(4):203-10. PMID: 6992153.
      Citations:    Fields:    Translation:Animals
    80. Woodson LC, Potter DE, Woodson LC, Potter DE. The influence of endogenous glucagon release on hyperglycemic responses to catecholamines in normal fed and diabetic rats. J Pharmacol Exp Ther. 1979 Sep; 210(3):458-64. PMID: 480194.
      Citations: 2     Fields:    Translation:Animals
    81. Rowland JM, Potter DE, Rowland JM, Potter DE. Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979; 212(2):65-75. PMID: 44821.
      Citations: 2     Fields:    Translation:Animals
    82. Potter DE, Rowland JM, Potter DE, Rowland JM. Adrenergic drugs and intraocular pressure: effects of selective beta-adrenergic agonists. Exp Eye Res. 1978 Dec; 27(6):615-25. PMID: 33056.
      Citations: 15     Fields:    Translation:Animals
    83. Woodson LC, Kempen RR, Bee DE, Potter DE, Woodson LC, Kempen RR, Bee DE, Potter DE. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons. Pharmacology. 1978; 17(4):221-6. PMID: 99754.
      Citations:    Fields:    Translation:Animals
    84. Potter DE, Wilson LM, Ellis S, Potter DE, Wilson LM, Ellis S. Changes in plasma glucose and insulin levels induced by adrenergic agents in normal and alloxan-diabetic rats. Proc Soc Exp Biol Med. 1977 Mar; 154(3):337-40. PMID: 851459.
      Citations: 2     Fields:    Translation:Animals
    85. Moratinos J, Ellis S, Potter DE, Moratinos J, Ellis S, Potter DE. Catecholamine-induced changes in plasma glucose and insulin levels in the unanesthetized rabbit. Pharmacology. 1977; 15(5):407-14. PMID: 918144.
      Citations: 2     Fields:    Translation:Animals
    86. Orr RK, Hoehn JL, Col NF, Potter DE, Ellis S. Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment. J Pharmacol Exp Ther. 1975 May; 193(2):576-84. PMID: 1142106.
      Citations: 3     Fields:    Translation:Animals
    87. Potter DE, Walaszek EJ, Potter DE, Walaszek EJ. Modification of polypeptide activity by cysteine analogs: structure-activity relationship. Pharmacology. 1971; 5(6):359-71. PMID: 5119544.
      Citations:    Fields:    Translation:Animals
    88. MCCARTHY DA, POTTER DE, NICOLAIDES ED, MCCARTHY DA, POTTER DE, NICOLAIDES ED. AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN. J Pharmacol Exp Ther. 1965 Apr; 148:117-22. PMID: 14279175.
      Citations: 17     Fields:    Translation:Animals
    Potter's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (355)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _